EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

By Peter R. Galle, Alejandro Forner1 , 2, J. Llovet, V. Mazzaferro, F. Piscaglia, J. Raoul, P. Schirmacher, V. Vilgrain. Journal of Hepatology, 2018

8,228 citations recorded by the source corpus.

Summary Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/dab431945721e9e7b2d29428283ea465b8f809e4